Lentigen Corporation Receives Funding From The State Of Maryland

Published: Dec 13, 2005

BALTIMORE, Dec. 13 /PRNewswire/ -- Lentigen Corporation, a privately held biotechnology company focused on the manufacturing and development of lentiviral vectors, announced that the company has secured financing through the state of Maryland's Department of Business and Economic Development Challenge Investment Program. The program was initiated by the State of Maryland to support the growth and development of emerging businesses throughout the State. This additional capital will assist Lentigen in the continued development and commercialization of its key lentiviral technology.

Dr. Boro Dropulic, Lentigen founder and CEO, commented, "We appreciate this support from the State of Maryland, and look forward to using this capital in building an important and innovative biotechnology company."

"Our investment in biotechnology companies such as Lentigen is one reason that Maryland has become a model for other states working to create and develop their technology sectors," said Aris Melissaratos, Secretary of Business and Economic Development. "By nurturing and supporting these companies through the initial stages of research and development, we are ensuring that Maryland's technology companies continue to grow, successfully bring their products to the commercial marketplace, and ultimately provide well-paying jobs to their communities."

About Lentigen Corporation

Lentigen Corporation is a privately owned biotechnology company focused on the manufacture of lentiviral vectors using its Lentiviral vector gene delivery technology for a wide range of applications in biotechnology and medicine. Lentiviral vectors are highly adapted delivery vehicles that can transport genes or gene silencing sequences into cells with high efficiency and stability. Lentigen is positioning itself to become the leading provider of Lentiviral vector products and services for academic, government, biotechnology and pharmaceutical researchers. For further information, visit http://www.Lentigen.com.

DBED's Mission

DBED's mission is to attract new businesses, stimulate private investment and create jobs, encourage the expansion and retention of existing companies and provide businesses in Maryland with workforce training and financial assistance. The department promotes the State's many economic advantages and markets local products and services at home and abroad to spur economic development, international trade and tourism. Because they are a major economic generator, the department also supports the arts, film production, sports and other special events.

Lentigen Corporation

CONTACT: Greg Feulner, VP Business Development of Lentigen Corporation,+1-443-543-5318, greg.feulner@lentigen.com; or Andrea Thomas Harrison ofMaryland Dept. of Business and Economic Development, +1-410-767-6325,aharrison@choosemaryland.org; Media: Gregory Tiberend of Richard LewisCommunications, Inc., +1-212-827-0020, gtiberend@rlcinc.com; or Investor:Tara Spiess of TS Communications Group, LLC, +1-914-921-5900,spiess@biotechirpr.com

Back to news